| Eyecontact Inc. | |
|
1720 Mars Hill Rd Nw Ste 160, Acworth, GA 30101-8089 | |
| (770) 529-1925 | |
| (770) 529-1982 |
| Full Name | Eyecontact Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1720 Mars Hill Rd Nw Ste 160, Acworth, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407054232 | NPI | - | NPPES |
| 763412534A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2200 (Georgia) | Primary |
| Provider Name | Robert W Mobley |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609801323 PECOS PAC ID: 8729036769 Enrollment ID: I20050106000739 |
News Archive
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
News outlets take a closer look at the circumstances around how members of Congress and their staffs are navigating getting health coverage on the DC insurance exchange - and just who is required to do so and by when.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
› Verified 1 days ago
| Provider Name | Leah Herron |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174972111 PECOS PAC ID: 4082907746 Enrollment ID: I20160719001236 |
News Archive
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
News outlets take a closer look at the circumstances around how members of Congress and their staffs are navigating getting health coverage on the DC insurance exchange - and just who is required to do so and by when.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
› Verified 1 days ago
| Provider Name | Brady P. Hanlon |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1114914017 PECOS PAC ID: 7719920644 Enrollment ID: I20180830001479 |
News Archive
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
News outlets take a closer look at the circumstances around how members of Congress and their staffs are navigating getting health coverage on the DC insurance exchange - and just who is required to do so and by when.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
› Verified 1 days ago
| Provider Name | Eric C Jan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285862110 PECOS PAC ID: 4880867258 Enrollment ID: I20191117000003 |
News Archive
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
News outlets take a closer look at the circumstances around how members of Congress and their staffs are navigating getting health coverage on the DC insurance exchange - and just who is required to do so and by when.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eyecontact Inc. 1720 Mars Hill Rd Nw Ste 160, Acworth, GA 30101-8089 Ph: (770) 529-1925 | Eyecontact Inc. 1720 Mars Hill Rd Nw Ste 160, Acworth, GA 30101-8089 Ph: (770) 529-1925 |
News Archive
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
News outlets take a closer look at the circumstances around how members of Congress and their staffs are navigating getting health coverage on the DC insurance exchange - and just who is required to do so and by when.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
› Verified 1 days ago
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6121 Cedarcrest Rd Nw Ste 108, Acworth, GA 30101 Phone: 770-529-7789 Fax: 770-529-7791 | |
William Wang Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 3826 Cobb Parkway N, Acworth, GA 30101 Phone: 770-966-1914 | |
Dr. John E. Valle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6121 Cedarcrest Rd Nw Ste 108, Acworth, GA 30101 Phone: 770-529-7789 Fax: 770-529-7791 | |
Dr. Julie Adams Poteet, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6121 Cedarcrest Rd Nw Ste 108, Acworth, GA 30101 Phone: 770-529-7789 Fax: 770-529-7791 | |
Kristy Q. Le Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 3378 Cobb Pkwy Nw, Acworth, GA 30101 Phone: 954-224-3428 Fax: 801-697-5328 | |
Dr. Erik Joseph Kelly, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4900 Ivey Rd Nw Ste 1226, Acworth, GA 30101 Phone: 770-974-3153 | |
Acworth Family Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 3459 Acworth Due West Rd Nw, Suite 101, Acworth, GA 30101 Phone: 770-974-3153 |